Cargando…

A multi-centre randomised Phase III trial of radioembolisation (RE) combined with oxmdg compared with oxmdg alone as first-line therapy for unresectable liver-only or liver-dominant metastatic colorectal cancer (CRC)

Detalles Bibliográficos
Autores principales:	Maycock, Nicola, Dutton, Susan, Sharma, Ricky
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981624/ http://dx.doi.org/10.1186/1745-6215-14-S1-P21

Ejemplares similares

FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer
por: Dutton, Susan J, et al.
Publicado: (2014)

Radioembolisation in patients with hepatocellular carcinoma that have previously received liver-directed therapies
por: Sangro, Bruno, et al.
Publicado: (2018)

Liver CT for vascular mapping during radioembolisation workup: comparison of an early and late arterial phase protocol
por: van den Hoven, Andor F., et al.
Publicado: (2016)

Trans-arterial hepatic radioembolisation of yttrium-90 microspheres
por: Murthy, R, et al.
Publicado: (2006)

Radioembolisation in Europe: A Survey Amongst CIRSE Members
por: Reinders, Margot T. M., et al.
Publicado: (2018)

Clinical and imaging-based prognostic factors in radioembolisation of liver metastases from colorectal cancer: a retrospective exploratory analysis
por: Willowson, Kathy P., et al.
Publicado: (2017)

Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model
por: Vente, M. A. D., et al.
Publicado: (2009)

Recommendations for radioembolisation after liver surgery using yttrium-90 resin microspheres based on a survey of an international expert panel
por: Samim, Morsal, et al.
Publicado: (2017)

Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases
por: Cosimelli, M, et al.
Publicado: (2010)

Radiosensitivity of colorectal cancer to (90)Y and the radiobiological implications for radioembolisation therapy
por: Lee, Boon Q, et al.
Publicado: (2019)

Personalised Dosimetry in Radioembolisation for HCC: Impact on Clinical Outcome and on Trial Design
por: Garin, Etienne, et al.
Publicado: (2020)

Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma
por: Najran, Pavan, et al.
Publicado: (2017)

Bevacizumab plus FOLFOX or FOLFIRI regimens on patients with unresectable liver-only metastases of metastatic colorectal cancer
por: Mehrzad, Valiollah, et al.
Publicado: (2016)

Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added Value
por: Mosconi, Cristina, et al.
Publicado: (2022)

Advances in liver transplantation for unresectable colon cancer liver metastasis
por: Cui, Xiao, et al.
Publicado: (2021)

Treatment response after radioembolisation in patients with hepatocellular carcinoma—An evaluation with dual energy computed-tomography
por: Altenbernd, Jens, et al.
Publicado: (2016)

Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma
por: Chew, Valerie, et al.
Publicado: (2019)

Radiological and Clinical Efficacy of Intra-Arterial (90)Y-DOTATATE in Patients with Unresectable, Progressive, Liver Dominant Neuroendocrine Neoplasms
por: Kolasińska-Ćwikła, Agnieszka, et al.
Publicado: (2021)

MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation
por: van de Maat, Gerrit H., et al.
Publicado: (2012)

Comparison of the Biograph Vision and Biograph mCT for quantitative (90)Y PET/CT imaging for radioembolisation
por: Kunnen, Britt, et al.
Publicado: (2020)

PROTOCOL FOR LIVER TRANSPLANTATION IN UNRESECTABLE COLORECTAL METASTASIS
por: ERNANI, Lucas, et al.
Publicado: (2022)

Perioperative FOLFOX4 plus bevacizumab for initially unresectable advanced colorectal cancer (NAVIGATE-CRC-01)
por: Suenaga, Mitsukuni, et al.
Publicado: (2015)

Y(90)-radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers
por: Rivoltini, Licia, et al.
Publicado: (2023)

Surgical Options for Initially Unresectable Colorectal Liver Metastases
por: Popescu, Irinel, et al.
Publicado: (2012)

Preparing the anatomical model for ablation of unresectable liver tumor
por: Spinczyk, Dominik
Publicado: (2014)

Liver Transplantation for Unresectable Metastases from Colon Adenocarcinoma
por: Caicedo, Luis Armando, et al.
Publicado: (2017)

Prognostic and predictive value of liver volume in colorectal cancer patients with unresectable liver metastases
por: Park, Jun Su, et al.
Publicado: (2014)

A contemporary systematic review on liver transplantation for unresectable liver metastases of colorectal cancer
por: Lebeck Lee, Cody M., et al.
Publicado: (2022)

Role of Kupffer cells in the progression of CRC liver metastases after the first stage of ALPPS
por: García-Pérez, Rocio, et al.
Publicado: (2018)

Efficacy and Safety of Trans-Arterial Yttrium-90 Radioembolization in Patients with Unresectable Liver-Dominant Metastatic or Primary Hepatic Soft Tissue Sarcomas
por: Testa, Stefano, et al.
Publicado: (2022)

Evaluation on Efficacy and Safety of Arsenic Trioxide Plus Transcatheter Arterial Chemoembolization Versus Transcatheter Arterial Chemoembolization alone for Unresectable Primary Liver Cancer
por: Yang, Haitao, et al.
Publicado: (2017)

Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: A cohort study
por: Braat, Arthur J. A. T., et al.
Publicado: (2017)

Does Radiofrequency Ablation Add to Chemotherapy for Unresectable Liver Metastases?
por: Govaert, Klaas M., et al.
Publicado: (2012)

Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies
por: Burgmans, Mark C., et al.
Publicado: (2015)

Liver Transplantation in Locally Unresectable, Undifferentiated Embryonal Cell Sarcoma
por: Babu, Benoy I., et al.
Publicado: (2021)

Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases
por: Kawamura, Junichiro, et al.
Publicado: (2016)

Unresectable Undifferentiated Embryonal Sarcoma of the Liver in an Adult Male Treated with Chemotherapy and Orthotopic Liver Transplantation
por: Khan, Zarak H, et al.
Publicado: (2017)

Recipient and Donor Outcomes After Living-Donor Liver Transplant for Unresectable Colorectal Liver Metastases
por: Hernandez-Alejandro, Roberto, et al.
Publicado: (2022)

Re-expression of REG family and DUOXs genes in CRC organoids by co-culturing with CAFs
por: Naruse, Mie, et al.
Publicado: (2021)

Chemotherapy Plus Cetuximab versus Chemotherapy Alone for Patients with KRAS Wild Type Unresectable Liver-Confined Metastases Colorectal Cancer: An Updated Meta-Analysis of RCTs
por: Lv, W., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9ilrura67jcuurdedlcc761piv